T-VEC and checkpoint therapy for melanoma
5 Jun 2017
T-VEC and checkpoint therapy for melanoma
Treating advanced melanoma with ipilimumab and HF10
Editor's Choice for May 2017
EADO conference highlights
Theory and application of electrochemotherapy
Intralesional T-VEC and combinations for melanoma
Role of histologic regression in melanoma
Molecular testing for targeted therapies
Brain metastases: Gamma knife and new treatments
Essential regional control of skin cancers
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
Circulating tumour cells in melanoma